Pharmacological and rehabilitation strategies in opioid-induced constipation: an observational study.
Salvatore Caramma, Rosaria Condorelli, Enrico Buccheri and 6 others
PMID 41647689WHAT IT FOUND
Adding rehab to Naldemedine didn't improve bowel function or pain more than Naldemedine alone.
Both groups improved. The rehab group reported higher satisfaction, likely due to self-efficacy rather than physiological changes.
Key findings
01Between-group comparisons revealed statistically significant differences only for patient-reported satisfaction outcomes at three months.
02The combined Naldemedine + rehabilitation approach was not associated with greater improvements in abdominal pain or bowel function compared with Naldemedine alone.
03Group allocation was based on patients' willingness to participate in the rehabilitation program, introducing potential self-selection bias.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was retrospective and non-randomized, with patients self-selecting into the rehabilitation group based on willingness. This introduces significant bias, as those who chose rehab may have been more motivated or had different baseline attitudes. Adherence to the rehabilitation program was self-reported and not objectively monitored, so it is unclear how much of the intervention was actually performed. The sample size was small (53 patients), and no correction for multiple testing was applied, increasing the risk of false positives. Opioid types and doses varied among participants, which could confound bowel function outcomes since different opioids have different constipation profiles.
Declared interests
No specific funding sources or conflicts of interest were declared in the provided text.
The easy way to misread this
Do not conclude that rehabilitation is ineffective for OIC. The study shows it did not add physiological benefit over Naldemedine alone in this specific non-randomized context, but it did improve patient satisfaction. The lack of randomization means we cannot rule out that self-selection influenced the results.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →